Why the study?
Is non-Hispanic Black race/ethnicity associated with a higher prevalence of adverse left ventricular remodeling compared to non-Hispanic White race/ethnicity in patients with chronic kidney disease?
Is non-Hispanic Black race/ethnicity associated with a higher prevalence of adverse left ventricular remodeling compared to non-Hispanic White race/ethnicity in patients with chronic kidney disease?
In patients with chronic kidney disease, non-Hispanic Black race is independently associated with a significantly higher prevalence of concentric left ventricular hypertrophy compared to non-Hispanic White race.
Answers are grounded in this paper and cite their sources.
Highlights racial disparities in adverse cardiac remodeling among patients with CKD; leaves open whether targeted screening.
BACKGROUND: Chronic kidney disease (CKD) is associated with increased risk of cardiovascular disease (CVD) and it is especially common among Blacks. Left ventricular hypertrophy (LVH) is an important subclinical marker of CVD, but there are limited data on racial variation in left ventricular structure and function among persons with CKD. METHODS: In a cross-sectional analysis of the Chronic Renal Insufficiency Cohort Study, we compared the prevalence of different types of left ventricular remodeling (concentric hypertrophy, eccentric hypertrophy, and concentric remodeling) by race/ethnicity. We used multinomial logistic regression to test whether race/ethnicity associated with different types of left ventricular remodeling independently of potential confounding factors. RESULTS: We identified 1,164 non-Hispanic Black and 1,155 non-Hispanic White participants who completed Year 1 visits with echocardiograms that had sufficient data to categorize left ventricular geometry type. Compared to non-Hispanic Whites, non-Hispanic Blacks had higher mean left ventricular mass index (54.7 ± 14.6 vs. 47.4 ± 12.2 g/m2.7; P < 0.0001) and prevalence of concentric LVH (45.8% vs. 24.9%). In addition to higher systolic blood pressure and treatment with >3 antihypertensive medications, Black race/ethnicity was independently associated with higher odds of concentric LVH compared to White race/ethnicity (odds ratio: 2.73; 95% confidence interval: 2.02, 3.69). CONCLUSION: In a large, diverse cohort with CKD, we found significant differences in left ventricular mass and hypertrophic morphology between non-Hispanic Blacks and Whites. Future studies will evaluate whether higher prevalence of LVH contribute to racial/ethnic disparities in cardiovascular outcomes among CKD patients.
No takes yet. Share an insight, caveat, or question.
Ahmad et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: